Skip to main content
Top
Published in: Annals of Nuclear Medicine 9/2016

Open Access 01-11-2016 | Original Article

Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT

Authors: Masanari Nonokuma, Yasuo Kuwabara, Kosuke Hida, Tomonobu Tani, Koichi Takano, Kengo Yoshimitsu

Published in: Annals of Nuclear Medicine | Issue 9/2016

Login to get access

Abstract

Objective

The aim of this study is to establish the optimal regions of interest (ROIs) in anatomically normalized I-123 FP-CIT SPECT images for the quantification of dopamine transporter binding.

Methods

The subjects comprised 16 normal controls and 14 Parkinsonian patients. All of the normal control subjects underwent I-123 FP-CIT SPECT and MRI. The SPECT device used in this study was a Toshiba GCA-9300R with triple head detectors. I-123 FP-CIT (148 MBq) was intravenously administered as a bolus, and the SPECT scan started 4 h after the administration. The data were collected over 20 min for each subject, and reconstructed using a 3D-OSEM algorithm. The data were analyzed using SPM8. I-123 FP-CIT SPECT images were anatomically normalized to the MNI space using an I-123 FP-CIT template, and then divided by the background counts automatically measured using the ROIs set for the cerebral cortices.

Results

In the normal control subjects, the specific binding ratios of the MRI-based ROIs were lowest in the caudate nucleus, while the ratios of the I-123 FP-CIT-based ROIs were almost the same throughout all three parts. In contrast, in Parkinsonian patients, the specific binding ratios of the I-123 FP-CIT-based ROIs revealed rostrocaudal decline, while those of the MRI-based ROIs were highest in the anterior putamen.

Conclusion

We created an ROI template on the anatomically normalized MRI and I-123 FP-CIT images, and concluded that I-123 FP-CIT-based ROIs are more suitable for obtaining quantitative values than MRI-based ones.
Literature
1.
go back to reference Badiavas K, Molyvda E, Iakovou I, Tsolaki M, Psarrakos K, Karatzas N. SPECT imaging evaluation in movement disorders: far beyond visual assessment. Eur J Nucl Med. 2010;38(4):764–73.CrossRef Badiavas K, Molyvda E, Iakovou I, Tsolaki M, Psarrakos K, Karatzas N. SPECT imaging evaluation in movement disorders: far beyond visual assessment. Eur J Nucl Med. 2010;38(4):764–73.CrossRef
2.
go back to reference Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, et al. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson’s disease. J Nucl Med. 1998;39:1143–8.PubMed Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, et al. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson’s disease. J Nucl Med. 1998;39:1143–8.PubMed
3.
go back to reference Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, et al. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson’s patients. J Nucl Med. 1998;39:1500–8.PubMed Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, et al. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson’s patients. J Nucl Med. 1998;39:1500–8.PubMed
4.
go back to reference Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases: rostrocaudal distribution. Brain. 1999;122:1449–68.CrossRefPubMed Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases: rostrocaudal distribution. Brain. 1999;122:1449–68.CrossRefPubMed
5.
6.
go back to reference Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med. 2006;24(7):538–44.CrossRefPubMed Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med. 2006;24(7):538–44.CrossRefPubMed
7.
go back to reference Huertas-Fernández I, García-Gómez F, García-Solís D, Benítez-Rivero S, Marín-Oyaga V, Jesús S, et al. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [123I]FP-CIT SPECT. Eur J Nucl Med. 2014;42(1):112–9.CrossRef Huertas-Fernández I, García-Gómez F, García-Solís D, Benítez-Rivero S, Marín-Oyaga V, Jesús S, et al. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [123I]FP-CIT SPECT. Eur J Nucl Med. 2014;42(1):112–9.CrossRef
8.
go back to reference Koch W, Radau PE, Hamann C, Tatsch Klaus. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med. 2005;46:1109–18.PubMed Koch W, Radau PE, Hamann C, Tatsch Klaus. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med. 2005;46:1109–18.PubMed
9.
go back to reference Cuberas-Borrós G, Lorenzo-Bosquet C, Aguadé-Bruix S, Hernández-Vara J, Pifarré-Montaner P, Miquel F, et al. Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism. Clin Nucl Med. 2011;36(11):991–6.CrossRefPubMed Cuberas-Borrós G, Lorenzo-Bosquet C, Aguadé-Bruix S, Hernández-Vara J, Pifarré-Montaner P, Miquel F, et al. Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism. Clin Nucl Med. 2011;36(11):991–6.CrossRefPubMed
10.
go back to reference Takada S, Yoshimura M, Shindo H, Saito K, Koizumi K, Utsumi H, et al. New semiquantitative assessment of123I-FP-CIT by an anatomical standardization method. Ann Nucl Med. 2006;20(7):477–84.CrossRefPubMed Takada S, Yoshimura M, Shindo H, Saito K, Koizumi K, Utsumi H, et al. New semiquantitative assessment of123I-FP-CIT by an anatomical standardization method. Ann Nucl Med. 2006;20(7):477–84.CrossRefPubMed
11.
go back to reference Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35:1528–37.PubMed Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35:1528–37.PubMed
12.
13.
go back to reference Tossici-Bolt L, Hoffmann S, Kemp P, Mehta R, Fleming J. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med. 2006;33(12):1491–9.CrossRef Tossici-Bolt L, Hoffmann S, Kemp P, Mehta R, Fleming J. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med. 2006;33(12):1491–9.CrossRef
14.
go back to reference Koole M, Laere KV, de Walle RV, Vandenberghe S, Bouwens L, Lemahieu I, et al. MRI guided segmentation and quantification of SPECT images of the basal ganglia: a phantom study. Comput Med Imaging Graph. 2001;25(2):165–72.CrossRefPubMed Koole M, Laere KV, de Walle RV, Vandenberghe S, Bouwens L, Lemahieu I, et al. MRI guided segmentation and quantification of SPECT images of the basal ganglia: a phantom study. Comput Med Imaging Graph. 2001;25(2):165–72.CrossRefPubMed
Metadata
Title
Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT
Authors
Masanari Nonokuma
Yasuo Kuwabara
Kosuke Hida
Tomonobu Tani
Koichi Takano
Kengo Yoshimitsu
Publication date
01-11-2016
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 9/2016
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-016-1107-6

Other articles of this Issue 9/2016

Annals of Nuclear Medicine 9/2016 Go to the issue